Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Published on: May 14, 2020
“It was such a silly little thing, to dress up as a child might, and treat the whole thing like a big circus, but it provided a way to help both myself and others stay positive,” said Jones.
Published on: March 31, 2020
Phyllis Alsterberg was recently treated for non-Hodgkin lymphoma. She hasn’t left her home in New York City much since the coronavirus outbreak started because she has a weakened immune system and she’s worried about getting sick.
Published on: September 12, 2019
When Katie Dimmock, 26, learned she had cancer, she was actually a little relieved. “It was one of the worst – but at the same time best – moments,” said Dimmock.
Published on: July 25, 2019
The pharmaceutical company Allergan has recalled all BioCell textured breast implants at the request of the US Food and Drug Administration (FDA) because they have been linked to a rare type of lymphoma.
Published on: June 28, 2019
When Crystal Zunino was diagnosed with non-Hodgkin lymphoma in January 2015, she was just half-way through her first year as a new middle-school math teacher in Warner Robins, Georgia.
Published on: June 12, 2019
The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL).
Published on: December 6, 2018
The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), the first biosimilar drug to treat adults with some types of non-Hodgkin lymphoma.
